Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Dec 15, 2019; 11(12): 1141-1150
Published online Dec 15, 2019. doi: 10.4251/wjgo.v11.i12.1141
Published online Dec 15, 2019. doi: 10.4251/wjgo.v11.i12.1141
Figure 1 Expression of DNMT1 in different gastric diseases (×20).
A: Chronic superficial gastritis [negative expression; score, 0 (+)]; B: Atrophic gastritis with intestinal metaplasia [moderately positive expression; score, 2 (++)]; C: Gastric low-grade intraepithelial neoplasia [moderately positive expression; score, 4 (++)]; D: Gastric high-grade intraepithelial neoplasia [strongly positive expression; score, 6 (+++)]; E: Early gastric cancer [strongly positive expression; score, 9 (+++)].
- Citation: Ma TM, Sun LP, Dong NN, Sun MJ, Yuan Y. Protein expression trends of DNMT1 in gastrointestinal diseases: From benign to precancerous lesions to cancer. World J Gastrointest Oncol 2019; 11(12): 1141-1150
- URL: https://www.wjgnet.com/1948-5204/full/v11/i12/1141.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i12.1141